Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

CG Oncology (CGON) Revenue: 2023-2025

Historic Revenue for CG Oncology (CGON) over the last 2 years, with Sep 2025 value amounting to $1.7 million.

  • CG Oncology's Revenue rose 3774.42% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year increase of 224.12%. This contributed to the annual value of $1.1 million for FY2024, which is 458.33% up from last year.
  • Per CG Oncology's latest filing, its Revenue stood at $1.7 million for Q3 2025, which was up 3,103.85% from $52,000 recorded in Q1 2025.
  • CG Oncology's 5-year Revenue high stood at $1.7 million for Q3 2025, and its period low was $1,000 during Q4 2023.
  • For the 3-year period, CG Oncology's Revenue averaged around $340,111, with its median value being $111,000 (2024).
  • In the last 5 years, CG Oncology's Revenue surged by 45,500.00% in 2024 and then slumped by 90.17% in 2025.
  • Over the past 3 years, CG Oncology's Revenue (Quarterly) stood at $1,000 in 2023, then surged by 45,500.00% to $456,000 in 2024, then surged by 3,774.42% to $1.7 million in 2025.
  • Its last three reported values are $1.7 million in Q3 2025, $52,000 for Q1 2025, and $456,000 during Q4 2024.